Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Security class unavailable · CUSIP: 52886X107

Event date: 2023-12-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-296742
Form type
SC 13G/A
Filer
Lexeo Therapeutics, Inc.
CIK
CIK 1907108
Filed
Dec 15, 2023
Reporting period
Dec 11, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub